VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2022 | Approval of tisa-cel for follicular lymphoma

Mazyar Shadman, MD, MPH, Fred Hutchinson Cancer Research Center, Seattle, WA, comments on the recent approval of tisagenlecleucel (tisa-cel) for follicular lymphoma. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter